Cutaneous metastasis of transitional cell carcinoma in 12 dogs

Veterinary Pathology

Volumn 50, Issue 4, 2013, Pages 676-681

  Reed, L T ^a,b   Knapp, D W ^a   Miller, Margaret A ^a  

^a PURDUE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bladder cancer; Dog diseases; Immunohistochemistry; Neoplasm metastasis; Prox1; Transitional cell carcinoma; Urinary tract; Uroplakin III

Indexed keywords

UROPLAKIN 3;

ANIMAL; CARCINOMA, TRANSITIONAL CELL; DOG; DOG DISEASES; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; PATHOLOGY; SECONDARY; SKIN TUMOR; URINARY BLADDER NEOPLASMS; VETERINARY;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; DOG DISEASES; DOGS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS; UROPLAKIN III;

EID: 84883104629     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985812465326     Document Type: Article

References (15)

1. Arnold EA, Childress MO, Fourez LM, et al. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder J Vet Intern Med. 2011;25:1385-1390.
2. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering status as a risk factor for canine prostate cancer. Prostate. 2007;67:1174-1181.
3. Ginn PE, Mansell JL, Rakich PM. The skin and appendages. In: MaxieMG, ed. Jubb, Kennedy and Palmer's Pathology of Domestic Animals. Vol 1. 5th ed. St Louis, MO: Elsevier; 2007:553-781.
4. Khan KM, Knapp DW, Denicola DB, et al. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res. 2000;61(5):478-481.
5. Knapp DW. Tumors of the urinary system. In: Withrow SJ, Vail DM, eds. Withrow and MacEwen's Small Animal Clinical Oncology. 4th ed. St Louis, MO: Saunders; 2007:649-658.
6. Knapp DW, Glickman NW, De Nicola DB. Naturally-occurring canine transitional cell carcinoma of the urinary bladder a relevant model of human invasive bladder cancer. Urol Oncol. 2000;5(2):47-59.
7. Meuten DJ. Tumors of the urinary system. In: Meuten DJ, ed. Tumors in Domestic Animals. 4th ed. Ames, IA: Iowa State Press; 2002:509-546.
8. Meuten DJ, Everitt J, Inskeep W. Histological Classification of Tumors of the Urinary System of Domestic Animals. Washington, DC: Armed Forces Institute of Pathology; 2004:28-30.
9. Mishima K, Watabe T, Saito A. Prox1 induces lymphatic endothelial differentiation via integrin α9 and other signaling cascades. Mol Biol Cell. 2007;18(4):1421-1429.
10. Mohammed SI, Knapp DW, Bostwick DG, et al. Expression of cyclooxygenase-2 in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Canc Res. 1999;59(22):5647-5650.
11. Mueller TJ, Wu H, Greenber RE, et al. Cutaneous metastasis from genitourinary malignancies. Urol J. 2004;63(6) 1021-1026.
12. Mutsaers AJ, Widmer WR, Knapp DW. Canine transitional cell carcinoma. J Vet Intern Med. 2003;17:136-144.
13. Ramos-Vara JA, Miller MA, Boucher M, et al. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Vet Pathol. 2003;40(1):55-62.
14. Salemis NS, Gakis C, Zografidis A, et al. Cutaneous metastasis of transitional cell bladder carcinoma: a rare presentation and literature review. J Cancer Res Ther. 2011;7(2):217-219.
15. Wigle JT, Harvey N, Detmar M. An essential role of Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21(7):1505-1513.